Posts Tagged: research and development


Enabling Technologies and the Underinvestment Problem

Certain innovations—known as enabling technologies—provide the foundation for progress across a range of industries. Enabling technologies include mobile wireless, the laser, CT scanners, the microprocessor, …
By David Teece
3 months ago 2

Want a greater ROI for taxpayers? Restore the patent system, protect Bayh-Dole and cut the red tape strangling federal labs

Three events boosted our economic turnaround in the 1980's: the passage of Bayh-Dole, which injected the incentives of patent ownership into the federal R&D system; the …
By Joseph Allen
3 months ago 6

Why Fewer Patent Applications are Being Filed

Over the next few years, the most interesting intellectual property trend to watch will be what happens with new patent applications. The number of utility patent applications …
By Amanda G. Ciccatelli
6 months ago 25

When Failure Becomes an Asset

Failure is success if we learn. So why shouldn't failure qualify as a trade secret? Competitors would love to avoid making the effort and taking the risk... …
By James Pooley
10 months ago 2

WIPO and pharmaceutical industry joining forces to improve meds patent info

Protecting innovation through patents is the lifeblood of the global pharmaceutical industry. Without patents the world and its expanding population would be deprived of new and, ultimately, …
By Thomas Cueni
12 months ago 1

Bernie Sander’s Really Bad Idea

Sen. Bernie Sanders (I-VT) introduced legislation requiring every agency and non-profit entity to include a "reasonable pricing" provision based on King's formula for any life science invention …
By Joseph Allen
1 year ago 14

Restricting Patents on New Combinations and Uses of Medicines Makes No Sense

IP-skeptics charge that these inventions are little more than a way for pharmaceutical companies to cynically prolong patent life and maximize profits, without providing any meaningful innovation. …
By Philip Stevens & Jack Ellis
1 year ago 5

Innovation is a Terrible Thing To Waste

Given the complexity of many technologies, the rapidly changing nature of global markets, and the legal complexities in establishing worldwide licensing programs, it should come as no …
By Sabina Brufani
2 years ago 0

Early Stage Innovation’s Chance to Save Itself

Universities in particular must explain to their congressional delegations why R&D must continue to be funded and why its Bayh-Dole based commercialization bridge must be protected …
By Chris Gallagher
2 years ago 0

Intel R&D increases lead to 36% jump in U.S. patent grants

The recent earnings release from Intel also indicates that the company is increasing its investment in research and development. Intel reported that R&D expenditures were $12.7 billion …
By Steve Brachmann
2 years ago 0

IBM achieves record number of U.S. patents in 2016, 24th straight year of patent dominance

In 1992, Bill Clinton was elected President of the United States. Hurricane Andrew bore down on the American Southeast, causing billions in damage after wreaking destruction from Florida …
By Steve Brachmann
2 years ago 2

Advice for the Trump Administration and New Congress: Protect Bayh-Dole and Restore the Patent System

Bayh-Dole is running on autopilot without Executive branch oversight and U.S. patents are no longer the world's gold standard. Without a course correction, we could be …
By Joseph Allen
2 years ago 3

Canada’s Promise Doctrine Should Be a Warning to America

A recent Canadian survey (CRA Survey) has conclusively attributed lowered levels of R&D investment in Canada’s innovation ecosystem to the country’s unique judicial “Promise …
By Chris Gallagher
2 years ago 11

UN Secretary General’s Panel on Access to Medicines Reports: Government Knows Best

Delayed for months beyond its expected issue date the Secretary General's High Level Panel on Access to Medicine's report emerged yesterday. Apparently the panelists scrambled to better …
By Joseph Allen
2 years ago 4

Federal funding for a cancer moonshot is not a terrible idea

To hear Ars Technica say it is ''a terrible idea'' to devote increased funding in order to eradicate cancer is astonishing on many levels. As part of …

Our website uses cookies to provide you with a better experience. Read our privacy policy for more information.Accept and Close